BRIEF published on 07/25/2024 at 12:02, 1 year 4 months ago Willkie Advises 3i Group on Sale of Weener Plastics Corporate Transaction 3i Group Weener Plastics Silgan Holdings Legal Advisory
BRIEF published on 07/25/2024 at 12:02, 1 year 4 months ago Willkie conseille le groupe 3i sur la vente de Weener Plastics Transaction D'entreprise Silgan Holdings Groupe 3i Plastiques Weener Conseil Juridique
PRESS RELEASE published on 07/25/2024 at 11:57, 1 year 4 months ago Willkie advises 3i Group plc on its sale of Weener Plastics Willkie advises 3i Group plc on sale of Weener Plastics, a global supplier of plastic packaging solutions, to Silgan Holdings Inc for EUR 838 million Weener Plastics Willkie 3i Group Plc Silgan Holdings Inc EUR 838 Million
PRESS RELEASE published on 05/11/2023 at 15:07, 2 years 6 months ago Willkie Farr & Gallagher LLP: Willkie advised Ardian on the acquisition financing of LIFTKET Group
Published on 12/05/2025 at 02:35, 4 hours 51 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 26 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 21 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 26 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 07:00, 26 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 3 hours 56 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 35 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 11 hours 1 minute ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 11 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 18:14, 13 hours 11 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 13 hours 26 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 13 hours 26 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 41 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 13 hours 41 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
